Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #35,651 to #35,700.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Nitrogen triiodide (2 revisions)
  2. Nitroglycerin (2 revisions)
  3. Nitroimidazole (2 revisions)
  4. Nitrosylation (2 revisions)
  5. Nitrox (2 revisions)
  6. No-reflow phenomenon coronary doppler imaging (2 revisions)
  7. No-reflow phenomenon historical perspective (2 revisions)
  8. No-reflow phenomenon other imaging findings (2 revisions)
  9. No-reflow phenomenon pathophysiology (2 revisions)
  10. Noble gas (2 revisions)
  11. Nocardiosis physical examination (2 revisions)
  12. Nocturnal Penile Tumescence (2 revisions)
  13. Nocturnal angina pectoris history and symptoms (2 revisions)
  14. Nocturnal angina pectoris pathophysiology (2 revisions)
  15. Nocturnal asthma CT (2 revisions)
  16. Nocturnal asthma MRI (2 revisions)
  17. Nocturnal asthma case study one (2 revisions)
  18. Nocturnal asthma chest x ray (2 revisions)
  19. Nocturnal asthma cost-effectiveness of therapy (2 revisions)
  20. Nocturnal asthma electrocardiogram (2 revisions)
  21. Nocturnal asthma future or investigational therapies (2 revisions)
  22. Nocturnal asthma other diagnostic studies (2 revisions)
  23. Nocturnal asthma other imaging findings (2 revisions)
  24. Nocturnal asthma primary prevention (2 revisions)
  25. Nocturnal asthma secondary prevention (2 revisions)
  26. Nocturnal myoclonus (2 revisions)
  27. Nocturnin (2 revisions)
  28. Nodular thyroid disease epidemiology and demographics (2 revisions)
  29. Nodular thyroid disease fine needle aspiration (2 revisions)
  30. Nodular thyroid disease historical perspective (2 revisions)
  31. Nodular thyroid disease overview (2 revisions)
  32. Nodular thyroid disease ultrasound (2 revisions)
  33. Nofetumomab merpentan (2 revisions)
  34. Noggin (protein) (2 revisions)
  35. Non-Polio enterovirus infections elecrocardiogram (2 revisions)
  36. Non-alcoholic fatty liver disease cost-effectiveness of therapy (2 revisions)
  37. Non-bacterial thrombotic endocarditis CT scan (2 revisions)
  38. Non-bacterial thrombotic endocarditis MRI (2 revisions)
  39. Non-bacterial thrombotic endocarditis causes (2 revisions)
  40. Non-bacterial thrombotic endocarditis cost-effectiveness of therapy (2 revisions)
  41. Non-bacterial thrombotic endocarditis electrocardiogram (2 revisions)
  42. Non-bacterial thrombotic endocarditis future or investigational therapies (2 revisions)
  43. Non-bacterial thrombotic endocarditis secondary prevention (2 revisions)
  44. Non-coding RNA (2 revisions)
  45. Non-coordinating ion (2 revisions)
  46. Non-mevalonate pathway (2 revisions)
  47. Non-noradrenergic, non-cholinergic transmitter (2 revisions)
  48. Non ST Elevation Myocardial Infarction: Genetics (2 revisions)
  49. Non ST Elevation Myocardial Infarction: Pathophysiology (2 revisions)
  50. Non ST elevation myocardial infarction pathophysiology & etiology (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)